Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine/Valproate vs Carbamazepine in Epilepsy
NCT00807989Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Mar 2008
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lamotrigine and valproic acid in epilepsy (2 arms), sponsored by Yonsei University. Primary endpoint: Retention Rate After 52 Weeks Maintenance Period. Started Mar 2008; status: completed.
02
Drugs
lamotriginevalproic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00807989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00807989.